title: Why continued surveillance? Intermittent blood pressure and heart rate abnormality under treatment.
abstract: Several opinion leaders have monitored their blood pressure systematically a sufficient number of times a day for chronomic (time structural) analyses, from the time of encountering chronobiology until their death; they set an example for others who also may not wish to base treatment on single spotchecks in a health care office. Such self-measurements, while extremely helpful, were not readily feasible without a noteworthy interruption of activities during waking as well as of sleep. New, relatively unobtrusive instrumentation now makes monitoring possible and cost-effective and will save lives. Illustrative results and problems encountered in an as-one-goes self-survey by GSK, a physician-scientist, are presented herein. Both MESOR-hypertension and CHAT (circadian hyper-amplitude-tension) can be intermittent conditions even under treatment, and treatment is best adjusted based on monitoring, rather than "flying blind".
authors.affiliation: Halberg Chronobiology Center, University of Minnesota, Minneapolis, MN, USA.
authors.forename: G S
authors.initials: GS
authors.lastname: Katinas
authors.forename: G
authors.initials: G
authors.lastname: Cornélissen
authors.forename: K
authors.initials: K
authors.lastname: Otsuka
authors.forename: E
authors.initials: E
authors.lastname: Haus
authors.forename: E E
authors.initials: EE
authors.lastname: Bakken
authors.forename: F
authors.initials: F
authors.lastname: Halberg
mesh_terms: D000328:Adult; D000959:Antihypertensive Agents / Q000627:therapeutic use; D001794:Blood Pressure / Q000187:drug effects / Q000502:physiology*; D002940:Circadian Rhythm / Q000502:physiology; D006339:Heart Rate / Q000187:drug effects / Q000502:physiology*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000503:physiopathology; D008297:Male; D008991:Monitoring, Physiologic; D010507:Periodicity; D012307:Risk Factors
chemical_list: D000959:Antihypertensive Agents